190 related articles for article (PubMed ID: 31107171)
61. Genome-editing technologies: the gap between application and policy.
Li G; Liu YG; Chen Y
Sci China Life Sci; 2019 Nov; 62(11):1534-1538. PubMed ID: 31686319
[No Abstract] [Full Text] [Related]
62. Tweaking genes with CRISPR or viruses fixes blood disorders.
Kaiser J
Science; 2020 Dec; 370(6522):1254-1255. PubMed ID: 33303593
[No Abstract] [Full Text] [Related]
63. CRISPR/Cas9 genome editing in human hematopoietic stem cells.
Bak RO; Dever DP; Porteus MH
Nat Protoc; 2018 Feb; 13(2):358-376. PubMed ID: 29370156
[TBL] [Abstract][Full Text] [Related]
64. CRISPR-Cas9; an efficient tool for precise plant genome editing.
Islam W
Mol Cell Probes; 2018 Jun; 39():47-52. PubMed ID: 29621557
[TBL] [Abstract][Full Text] [Related]
65. Programmable base editing of zebrafish genome using a modified CRISPR-Cas9 system.
Zhang Y; Qin W; Lu X; Xu J; Huang H; Bai H; Li S; Lin S
Nat Commun; 2017 Jul; 8(1):118. PubMed ID: 28740134
[TBL] [Abstract][Full Text] [Related]
66. Precise and efficient scarless genome editing in stem cells using CORRECT.
Kwart D; Paquet D; Teo S; Tessier-Lavigne M
Nat Protoc; 2017 Feb; 12(2):329-354. PubMed ID: 28102837
[TBL] [Abstract][Full Text] [Related]
67. Genome editing comes of age.
Kim JS
Nat Protoc; 2016 Sep; 11(9):1573-8. PubMed ID: 27490630
[TBL] [Abstract][Full Text] [Related]
68. Genome Editing: Past, Present, and Future.
Carroll D
Yale J Biol Med; 2017 Dec; 90(4):653-659. PubMed ID: 29259529
[TBL] [Abstract][Full Text] [Related]
69. CRISPR treatment inserted directly into the body for first time.
Ledford H
Nature; 2020 Mar; 579(7798):185. PubMed ID: 32157225
[No Abstract] [Full Text] [Related]
70. The Future of Genome Editing.
Cell; 2018 May; 173(6):1311-1313. PubMed ID: 29856947
[TBL] [Abstract][Full Text] [Related]
71. The CRISPR-Cas9 Genome Editing System: Not as Precise as Previously Believed.
Mattei TA
World Neurosurg; 2018 Oct; 118():377-378. PubMed ID: 30114543
[No Abstract] [Full Text] [Related]
72. The CRISPR/Cas9 Genome Editing Revolution.
Jiao R; Gao C
J Genet Genomics; 2016 May; 43(5):227-8. PubMed ID: 27256542
[No Abstract] [Full Text] [Related]
73. CRISPR-Cas Gene Editing to the Genetic Rescue.
Goetzl EJ; Alpert JS
Am J Med; 2024 May; 137(5):386-389. PubMed ID: 38281656
[No Abstract] [Full Text] [Related]
74. [Methods of Evaluating the Efficiency of CRISPR/Cas Genome Editing].
Lomov NA; Viushkov VS; Petrenko AP; Syrkina MS; Rubtsov MA
Mol Biol (Mosk); 2019; 53(6):982-997. PubMed ID: 31876277
[TBL] [Abstract][Full Text] [Related]
75. Baculoviral delivery of CRISPR/Cas9 facilitates efficient genome editing in human cells.
Hindriksen S; Bramer AJ; Truong MA; Vromans MJM; Post JB; Verlaan-Klink I; Snippert HJ; Lens SMA; Hadders MA
PLoS One; 2017; 12(6):e0179514. PubMed ID: 28640891
[TBL] [Abstract][Full Text] [Related]
76. A fast method to reprogram and CRISPR/Cas9 gene editing from erythroblasts.
Melo US; de Souza Leite F; Costa S; Rosenberg C; Zatz M
Stem Cell Res; 2018 Aug; 31():52-54. PubMed ID: 30015173
[TBL] [Abstract][Full Text] [Related]
77. Revolutionize Genetic Studies and Crop Improvement with High-Throughput and Genome-Scale CRISPR/Cas9 Gene Editing Technology.
Yang N; Wang R; Zhao Y
Mol Plant; 2017 Sep; 10(9):1141-1143. PubMed ID: 28803899
[No Abstract] [Full Text] [Related]
78. Efficient Genome Engineering of a Virulent Klebsiella Bacteriophage Using CRISPR-Cas9.
Shen J; Zhou J; Chen GQ; Xiu ZL
J Virol; 2018 Sep; 92(17):. PubMed ID: 29899105
[No Abstract] [Full Text] [Related]
79. CRISPR therapies march into clinic, but genotoxicity concerns linger.
Sheridan C
Nat Biotechnol; 2021 Aug; 39(8):897-899. PubMed ID: 34267391
[No Abstract] [Full Text] [Related]
80. 'Base editors' open new way to fix mutations.
Cohen J
Science; 2017 Oct; 358(6362):432-433. PubMed ID: 29074746
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
